Entera Bio shareholders approve authorized share increase at annual meeting - ENTX News | RalliesEntera Bio shareholders approve authorized share increase at annual meeting
E
ENTX• Shareholders approve share increase and plan amendment
- Entera Bio held its 2026 annual shareholder meeting on July 14, 2026.
- Shareholders backed an amendment raising authorized ordinary shares to 350,000,000 from 140,010,000; the change took effect upon approval.
- They also adopted a one-time increase of 2,500,000 ordinary shares available under the 2018 Equity Incentive Plan amendment.
- Shareholders ratified Kesselman & Kesselman as independent auditor for the fiscal year ending Dec. 31, 2026.
- An advisory vote on named executive officer pay passed.
•
